UROGEN PHARMA LTD

Ticker: URGN CUSIP: M96088105 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 16,300 Value ($000) $382 Avg Close $21.69 Range $15.86 - $30.00
Q3 2025
Shares 18,675 Value ($000) $373 Avg Close $17.96 Range $12.73 - $21.71
Q2 2025
Shares 20,660 Value ($000) $283 Avg Close $9.60 Range $3.42 - $15.61
Q1 2025
Shares 11,500 Value ($000) $127 Avg Close $10.66 Range $9.03 - $12.37
Q4 2024
Shares 136,491 Value ($000) $1,454 Avg Close $11.97 Range $10.26 - $13.64
Q2 2024
Shares 42,841 Value ($000) $719 Avg Close $14.22 Range $10.60 - $20.70
Q4 2023
Shares 28,552 Value ($000) $428 Avg Close $12.98 Range $10.63 - $16.32
Q3 2023
Shares 26,821 Value ($000) $376 Avg Close $16.05 Range $8.69 - $24.13
Q2 2023
Shares 86,880 Value ($000) $899 Avg Close $11.03 Range $8.57 - $16.11
Q1 2023
Shares 15,308 Value ($000) $141 Avg Close $9.20 Range $7.60 - $11.68
Q4 2019
Shares 1,769 Value ($000) $59 Avg Close $27.30 Range $20.72 - $35.21
Q3 2019
Shares 1,219 Value ($000) $29 Avg Close $32.69 Range $23.24 - $37.94